The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach
BACKGROUND: The prevention of tuberculosis (TB) is key for accelerating current, slow declines in TB burden. The 2018 World Health Organization (WHO) guidelines on eligibility for preventive therapy to treat latent TB infection (LTBI) include people living with human immunodeficiency virus (PLHIV),...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369473/ https://www.ncbi.nlm.nih.gov/pubmed/32684164 http://dx.doi.org/10.1186/s12916-020-01651-5 |